330 related articles for article (PubMed ID: 34465026)
41. Hsp21 potentiates antifungal drug tolerance in Candida albicans.
Mayer FL; Wilson D; Hube B
PLoS One; 2013; 8(3):e60417. PubMed ID: 23533680
[TBL] [Abstract][Full Text] [Related]
42. Ploidy plasticity: a rapid and reversible strategy for adaptation to stress.
Berman J
FEMS Yeast Res; 2016 May; 16(3):. PubMed ID: 26945893
[TBL] [Abstract][Full Text] [Related]
43. Emerging Mechanisms of Drug Resistance in Candida albicans.
Prasad R; Nair R; Banerjee A
Prog Mol Subcell Biol; 2019; 58():135-153. PubMed ID: 30911892
[TBL] [Abstract][Full Text] [Related]
44. Posaconazole exhibits in vitro and in vivo synergistic antifungal activity with caspofungin or FK506 against Candida albicans.
Chen YL; Lehman VN; Averette AF; Perfect JR; Heitman J
PLoS One; 2013; 8(3):e57672. PubMed ID: 23472097
[TBL] [Abstract][Full Text] [Related]
45. Metal Chelation as a Powerful Strategy to Probe Cellular Circuitry Governing Fungal Drug Resistance and Morphogenesis.
Polvi EJ; Averette AF; Lee SC; Kim T; Bahn YS; Veri AO; Robbins N; Heitman J; Cowen LE
PLoS Genet; 2016 Oct; 12(10):e1006350. PubMed ID: 27695031
[TBL] [Abstract][Full Text] [Related]
46. A chromosome 4 trisomy contributes to increased fluconazole resistance in a clinical isolate of Candida albicans.
Anderson MZ; Saha A; Haseeb A; Bennett RJ
Microbiology (Reading); 2017 Jun; 163(6):856-865. PubMed ID: 28640746
[TBL] [Abstract][Full Text] [Related]
47. Cryptococcus neoformans, Unlike Candida albicans, Forms Aneuploid Clones Directly from Uninucleated Cells under Fluconazole Stress.
Chang YC; Khanal Lamichhane A; Kwon-Chung KJ
mBio; 2018 Dec; 9(6):. PubMed ID: 30514783
[TBL] [Abstract][Full Text] [Related]
48. A tetraploid intermediate precedes aneuploid formation in yeasts exposed to fluconazole.
Harrison BD; Hashemi J; Bibi M; Pulver R; Bavli D; Nahmias Y; Wellington M; Sapiro G; Berman J
PLoS Biol; 2014 Mar; 12(3):e1001815. PubMed ID: 24642609
[TBL] [Abstract][Full Text] [Related]
49. Emodin Reduces the Activity of (1,3)-
Janeczko M
Pol J Microbiol; 2018; 67(4):463-470. PubMed ID: 30550232
[TBL] [Abstract][Full Text] [Related]
50. Stress alters rates and types of loss of heterozygosity in Candida albicans.
Forche A; Abbey D; Pisithkul T; Weinzierl MA; Ringstrom T; Bruck D; Petersen K; Berman J
mBio; 2011; 2(4):. PubMed ID: 21791579
[TBL] [Abstract][Full Text] [Related]
51. The SAGA and NuA4 component Tra1 regulates Candida albicans drug resistance and pathogenesis.
Razzaq I; Berg MD; Jiang Y; Genereaux J; Uthayakumar D; Kim GH; Agyare-Tabbi M; Halder V; Brandl CJ; Lajoie P; Shapiro RS
Genetics; 2021 Oct; 219(2):. PubMed ID: 34849885
[TBL] [Abstract][Full Text] [Related]
52. Progressive esophagitis caused by Candida albicans with reduced susceptibility to caspofungin.
Miller CD; Lomaestro BW; Park S; Perlin DS
Pharmacotherapy; 2006 Jun; 26(6):877-80. PubMed ID: 16716141
[TBL] [Abstract][Full Text] [Related]
53. Pyrosequencing to detect mutations in FKS1 that confer reduced echinocandin susceptibility in Candida albicans.
Wiederhold NP; Grabinski JL; Garcia-Effron G; Perlin DS; Lee SA
Antimicrob Agents Chemother; 2008 Nov; 52(11):4145-8. PubMed ID: 18794385
[TBL] [Abstract][Full Text] [Related]
54. Genomewide Elucidation of Drug Resistance Mechanisms for Systemically Used Antifungal Drugs Amphotericin B, Caspofungin, and Voriconazole in the Budding Yeast.
Balkan C; Ercan I; Isik E; Sahin Akdeniz E; Balcioglu O; Kodedová M; Zimmermannová O; Dundar M; Sychrová H; Koc A
Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31209012
[TBL] [Abstract][Full Text] [Related]
55. Overexpression of Candida albicans CDR1, CDR2, or MDR1 does not produce significant changes in echinocandin susceptibility.
Niimi K; Maki K; Ikeda F; Holmes AR; Lamping E; Niimi M; Monk BC; Cannon RD
Antimicrob Agents Chemother; 2006 Apr; 50(4):1148-55. PubMed ID: 16569823
[TBL] [Abstract][Full Text] [Related]
56. Endoplasmic reticulum-derived reactive oxygen species (ROS) is involved in toxicity of cell wall stress to Candida albicans.
Yu Q; Zhang B; Li J; Zhang B; Wang H; Li M
Free Radic Biol Med; 2016 Oct; 99():572-583. PubMed ID: 27650297
[TBL] [Abstract][Full Text] [Related]
57. Synergistic effect of nikkomycin Z with caspofungin and micafungin against Candida albicans and Candida parapsilosis biofilms.
Kovács R; Nagy F; Tóth Z; Bozó A; Balázs B; Majoros L
Lett Appl Microbiol; 2019 Oct; 69(4):271-278. PubMed ID: 31385615
[TBL] [Abstract][Full Text] [Related]
58. Genome-wide expression profiling of the response to azole, polyene, echinocandin, and pyrimidine antifungal agents in Candida albicans.
Liu TT; Lee RE; Barker KS; Lee RE; Wei L; Homayouni R; Rogers PD
Antimicrob Agents Chemother; 2005 Jun; 49(6):2226-36. PubMed ID: 15917516
[TBL] [Abstract][Full Text] [Related]
59. Puupehenone, a Marine-Sponge-Derived Sesquiterpene Quinone, Potentiates the Antifungal Drug Caspofungin by Disrupting Hsp90 Activity and the Cell Wall Integrity Pathway.
Tripathi SK; Feng Q; Liu L; Levin DE; Roy KK; Doerksen RJ; Baerson SR; Shi X; Pan X; Xu WH; Li XC; Clark AM; Agarwal AK
mSphere; 2020 Jan; 5(1):. PubMed ID: 31915228
[TBL] [Abstract][Full Text] [Related]
60. Multifactorial Role of Mitochondria in Echinocandin Tolerance Revealed by Transcriptome Analysis of Drug-Tolerant Cells.
Garcia-Rubio R; Jimenez-Ortigosa C; DeGregorio L; Quinteros C; Shor E; Perlin DS
mBio; 2021 Aug; 12(4):e0195921. PubMed ID: 34372698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
